ALFA FinderBSE filing, BSE: 543963. Summary written from the filing by ALFA Finder's alert engine.
Shelter Pharma Ltd: key numbers
- Share price
- ₹47.00
- Market cap
- ₹81.32 Cr
- Revenue (annual)
- ₹73.13 Cr
- Net profit (annual)
- ₹9.03 Cr
- P/E (TTM)
- 9.0×Sector 43.0×
- Promoter holding
- 46.11%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shelter Pharma Ltd
All →Shelter Pharma H1 FY27 Results: Net Profit ₹5.2 Cr, Up 15.6% YoY
Shelter Pharma Ltd reported revenue from operations of ₹45.1 Cr (+35.4% YoY) and net profit of ₹5.2 Cr (+15.6% YoY) for H1 FY27.
- Key figure
- Net profit ₹5.2 Cr · +15.6% YoY
Shelter Pharma Board Meeting Date
Shelter Pharma intimated its Board meeting is scheduled for November 7, 2026, to approve H1 FY27 unaudited results. Trading window remains closed until November 9, 2026.
Shelter Pharma Bags ₹0.22 Cr Order from First Vet Veterinary Medicines Trading L.L.C
Shelter Pharma won a USD 23,300 (Rs 0.22 Crore) export order from First Vet, UAE. Ordinary course business, executable per the purchase order schedule.
- Value
- ₹0.22 Cr
- From
- First Vet Veterinary Medicines Trading L.L.C
- Execution
- Within the mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹0.1 Cr Order from Genet International
Shelter Pharma won a Rs.0.10 Crore order from Genet International in Bangladesh. It covers 10,000 boxes in the normal course of business.
- Value
- ₹0.10 Cr
- From
- Genet International
- Execution
- Within mutually agreed timelines as per the purchase order schedule
Shelter Pharma Bags ₹3.15 Cr Order from Taha Drugs & Chemicals Co. Ltd.
Shelter Pharma Ltd received an international order from Taha Drugs & Chemicals Co. Ltd. worth Rs.3.15 Crore (USD 3,30,975). Execution follows mutually agreed purchase order schedules.
- Value
- ₹3.15 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.
- Execution
- Within mutually agreed timelines as per purchase order schedule
Shelter Pharma Bags ₹3.47 Cr Order from Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines...
Shelter Pharma received export orders worth Rs. 3.47 Crore from three overseas buyers. Execution follows mutually agreed purchase-order schedules, in the normal course of business.
- Value
- ₹3.47 Cr
- From
- Taha Drugs & Chemicals Co. Ltd.; First Vet Veterinary Medicines Trading L.L.C; Genet International
- Execution
- As per mutually agreed purchase order schedules
Other other announcement announcements
All →Capricorn Systems Global Solutions Other Announcement
Capricorn Systems reports rights issue proceeds fully utilised as of September 30, 2026, with no deviation. This is a routine Regulation 32 utilisation statement.
Thrive Future Habitats Other Announcement
Thrive Future Habitats Ltd filed its quarterly shareholding pattern for the quarter ended 30 September 2026. Note 1 records 93,12,364 shares allotted on warrant conversion, pending demat and lock-in.
Thyrocare Technologies Other Announcement
Designated person Rahul Guha bought 2,121 Thyrocare shares via market purchase on November 6, 2026, worth ₹0.10 Crore. Post-trade holding is 200,859 shares.
- Value
- ₹0.10 Cr
Aavas Financiers Other Announcement
AAVAS Financiers disclosed that Morningstar Sustainalytics improved its ESG risk score to 21.4 from 23.9. The rating was assigned voluntarily without company engagement.
Brijlaxmi Leasing & Finance Other Announcement
Brijlaxmi Leasing claims exemption from related party transaction disclosure under Regulation 23(9) for FY2025-26. Its capital and net worth fall within Regulation 15(2) limits.
Indrayani Biotech Other Announcement
Indrayani Biotech filed its quarterly shareholding pattern for 30 September 2026. Promoter group holds 32.89% of equity; this is routine compliance with no corporate event.